Morgan Stanley analyst Bob Huang lowered the firm’s price target on MetLife (MET) to $98 from $99 and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target raised to $97 from $94 at Wells Fargo
- MetLife price target raised to $94 from $88 at Barclays
- Ameriprise price target raised to $434 from $423 at Piper Sandler
- Brighthouse Financial price target lowered to $55 from $63 at Piper Sandler
- MetLife Announces $10 Billion Reinsurance Deal with Chariot